BEAM THERAPEUTICS INC. (BEAM)

Evans John M. 🟡 adjusted position in 40.0K shares (2 derivative) of Beam Therapeutics Inc. (BEAM) at $22.76 ($1.2M) Transaction Date: Mar 30, 2026 | Filing ID: 138348